Technical validation of a multiplex platform to detect thirty mutations in eight genetic diseases prevalent in individuals of Ashkenazi Jewish descent

This publication has 13 references indexed in Scilit:

• Mutation detection, interpretation, and applications in the clinical laboratory setting
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
• Carrier screening panels for Ashkenazi Jews: Is more better?
  Genetics in Medicine, 2005
• Analytical Validation of the Tag-It High-Throughput Microsphere-Based Universal Array Genotyping Platform: Application to the Multiplex Detection of a Panel of Thrombophilia-Associated Single-Nucleotide Polymorphisms
  Clinical Chemistry, 2004
• ACOG Committee Opinion #298
  Obstetrics & Gynecology, 2004
• Molecular screening for diseases frequent in Ashkenazi Jews: Lessons learned from more than 100,000 tests performed in a commercial laboratory
  Genetics in Medicine, 2004
• Direct Visualization of Cystic Fibrosis Transmembrane Regulator Mutations in the Clinical Laboratory Setting
  Clinical Chemistry, 2004
• Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France
  Human Mutation, 2003
• Genetic Susceptibility to Venous Thrombosis
  New England Journal of Medicine, 2001
• Laboratory standards and guidelines for population-based cystic fibrosis carrier screening
  Genetics in Medicine, 2001
• Sequence Analysis and Homology Modeling Suggest That Primary Congenital Glaucoma on 2p21 Results from Mutations Disrupting Either the Hinge Region or the Conserved Core Structures of Cytochrome P4501B1
  American Journal of Human Genetics, 1998